Not applicableStudy completedNCT02751879What this trial is testingReal World Data on Gi(l)Otrif® Dose AdjustmentWho this might be right forCarcinoma, Non-Small-Cell Lung Boehringer Ingelheim 228
Early research (Phase 1)Study completedNCT04164069What this trial is testingDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabWho this might be right forAdvanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more Anne Noonan 9
Testing effectiveness (Phase 2)Study completedNCT04197310What this trial is testingCabozantinib and Nivolumab for Carcinoid TumorsWho this might be right forCarcinoid TumorCarcinoid Tumor of GI SystemNeuroendocrine Tumors Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT03531320What this trial is testingStudy of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion PhaseWho this might be right forGastrointestinal CancerBiliary Tract Cancer InnoPharmax Inc. 19
Not applicableLooking for participantsNCT02906943What this trial is testingOntario-wide Cancer TArgeted Nucleic Acid EvaluationWho this might be right forBreast CancerLung CancerColorectal Cancer+8 more University Health Network, Toronto 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05651672What this trial is testingPemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 AlterationsWho this might be right forGastrointestinal Cancer Tianjin Medical University Cancer Institute and Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT02241720What this trial is testingRegorafenib Second Line Treatment of Metastatic or Advanced Upper GI CancersWho this might be right forUpper GI Cancer University of Utah 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07640737What this trial is testingAUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)Who this might be right forNeuroendocrine (NE) TumorsAdvanced NET of GI Origin Aurigene Discovery Technologies Limited 30
Early research (Phase 1)Looking for participantsNCT06065371What this trial is testingSacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard TherapyWho this might be right forGastrointestinal Cancer Henry Ford Health System 20
Large-scale testing (Phase 3)Study completedNCT00513357What this trial is testingMelatonin Versus Placebo and the Effect on Appetite in Advanced Cancer PatientsWho this might be right forGastrointestinal CancerLung Cancer M.D. Anderson Cancer Center 82
Not applicableEnded earlyNCT01374100What this trial is testingEffect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing ChemotherapyWho this might be right forCarcinoma, Non-Small-Cell LungCancer of the Gastrointestinal Tract McGill University 52
Early research (Phase 1)UnknownNCT04460456What this trial is testingSBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsWho this might be right forHER2 Positive Solid Tumors Silverback Therapeutics 58
Early research (Phase 1)Study completedNCT00047242What this trial is testingUCN-01 and Irinotecan in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT00209625What this trial is testingPhase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal CancerWho this might be right forColorectal Cancer Hokkaido Gastrointestinal Cancer Study Group 23
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Ended earlyNCT04214418What this trial is testingStudy of Combination Therapy With the MEK Inhibitor, Cobimetinib, Immune Checkpoint Blockade, Atezolizumab, and the AUTOphagy Inhibitor, Hydroxychloroquine in KRAS-mutated Advanced MalignanciesWho this might be right forGastrointestinal Cancer Columbia University 27
Testing effectiveness (Phase 2)Ended earlyNCT01648465What this trial is testingStudy of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine TumorsWho this might be right forGastrointestinal TumorsPancreatic TumorsGastrointestinal Neuroendocrine Tumors+1 more Hellenic Cooperative Oncology Group 25
Early research (Phase 1)Ended earlyNCT04729205What this trial is testingAssessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI MalignanciesWho this might be right forCancerGastro-Intestinal Intraepithelial Neoplasia Lipomedix Pharmaceuticals Inc. 9
Early research (Phase 1)Study completedNCT00544193What this trial is testingGemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more City of Hope Medical Center 16
Not applicableLooking for participantsNCT06420206What this trial is testingGoals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer CenterWho this might be right forLung CancerGastrointestinal Cancer M.D. Anderson Cancer Center 200